Author:
Bonfante-Cabarcas R.,Bravo I.,Nello C.,Gutiérrez-Reyes E.,Loureiro Dos Santos N. E.,Moreno-Yanes J. A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference35 articles.
1. Acton G, Dailey JW, Morris SW, McNatt L. Evidence for an endogenous factor interfering with antagonist binding at the muscarinic cholinergic receptor. Eur J Pharmacol 58:343–344;1979.
2. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414;1982.
3. Brauner-Osborne H, Brann MR. Pharmacology of muscarinic acetylcholine receptor subtypes (m1–m5): High throughput assays in mammalian cells. Eur J Pharmacol 295:93–102;1996.
4. Cain DP. Testing the NMDA, long-term potentiation, and cholinergic hypothesis of spatial learning. Neurosci Biobehav Rev 22:181–193;1998.
5. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 2:279–290;1998.